KALVISTA PHARMACEUTICALS LIMITED Patent Application Trends in 2024

KALVISTA PHARMACEUTICALS LIMITED patent applications in 2024

Top 10 Technology Areas

• A61K31/444 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• A61K9/2054 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• A61P7/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
  • Count: 1 patents
  • Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D401/02 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
• C07B2200/13 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation)
  • Count: 1 patents
  • Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
• C07D487/04 (Ortho-condensed systems)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D471/04 (Ortho-condensed systems)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D487/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)

Emerging Technology Areas

• C07D471/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D487/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D471/04 (Ortho-condensed systems)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07D487/04 (Ortho-condensed systems)
  • Count: 1 patents
  • Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• C07B2200/13 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation)
  • Count: 1 patents
  • Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
• C07D401/02 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
• A61P7/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
  • Count: 1 patents
  • Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
• A61K9/2054 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)

Top Inventors

• Hannah Joy EDWARDS (2 patents)
• Edward Paul FEENER of North Reading MA (US) (1 patent)
• Sally Louise MARSH (1 patent)
• Andreas MAETZEL of Chapel Hill NC (US) (1 patent)
• Michael David SMITH of Salt Lake City UT (US) (1 patent)
• Christopher Martyn YEA (1 patent)
• Haydn BEATON (1 patent)
• David Malcolm CROWE (1 patent)
• Mitchell Lewis CHILDS (1 patent)
• Rebecca Louise DAVIE (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors